WebSep 20, 2024 · Currently, CStone has received three drug approvals in Greater China, including two in Mainland China and one in Taiwan. CStone's vision is to become globally recognized as a world-renowned biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide. WebJun 27, 2024 · Agios Pharmaceuticals, Inc AGIO has entered into an exclusive collaboration and license agreement with China’s CStone Pharmaceuticals to develop and commercialize its pipeline candidate, Tibsovo ...
CStone Pharmaceuticals LinkedIn
WebOct 27, 2024 · CStone’s chairman and chief executive officer, Frank Jiang, pictured above. Photo courtesy of CStone. Biotechnology company EQRx is adding two immunotherapy drugs to its product lineup under a newly announced agreement with CStone Pharmaceuticals, a Chinese pharma company that has agreed to out-license the rights … Web1 day ago · China’s local maritime authorities have issued a warning for possible rocket debris in waters northeast of Taiwan, saying ships would be banned from entering the … in baseball another word for power hitter
CStone Pharmaceuticals SEHK:2616 Stock Report - Simply Wall St
WebMar 24, 2024 · CStone is a biopharmaceutical company focused on the development and commercialization of innovative tumor immunotherapy and precision medicines to meet the ardent medical needs of cancer patients ... WebNov 21, 2024 · Currently, CStone has received three drug approvals in Greater China, including two in Mainland China and one in Taiwan. CStone's vision is to become … WebJul 14, 2024 · The company raised about HK$2.6 billion ($327 million) in a Hong Kong initial public offering in 2024. WuXi Healthcare Ventures, the investment arm of Chinese pharmaceutical company Wuxi, is the biggest shareholder of CStone with a 24.7% stake, according to data compiled by Bloomberg. inbuilt objects in python